{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:44:38Z","timestamp":1750117478624},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.earlhumdev.2004.07.004","type":"journal-article","created":{"date-parts":[[2004,10,26]],"date-time":"2004-10-26T15:30:54Z","timestamp":1098804654000},"page":"281-287","source":"Crossref","is-referenced-by-count":5,"title":["Minor neurological dysfunction, cognitive development, and somatic development at the age of 3 to 7 years after dexamethasone treatment in very-low birth-weight infants"],"prefix":"10.1016","volume":"81","author":[{"given":"J.","family":"Kutschera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tomaselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Urlesberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2004.07.004_bib1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/adc.68.5_Spec_No.566","article-title":"Dexamethasone treatment in preterm infants at risk for bronchopulmonary dyplasia","volume":"68","author":"Kari","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1542\/peds.98.2.204","article-title":"A controlled trail of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants","volume":"98","author":"Rastogi","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1651-2227.1992.tb12096.x","article-title":"Randomized controlled trial of dexamethasone treatment in very-low-birthweight infants with ventilator-dependent chronic lung disease","volume":"81","author":"Ohlsson","year":"1992","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib4","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1007\/PL00014290","article-title":"Corticosteroids and neonatal chronic lung disease","volume":"157","author":"Bancalari","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM200101113440203","article-title":"Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants","volume":"344","author":"Stark","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib6","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.101.5.e7","article-title":"Early dexamethasone therapy in preterm infants: a follow-up study","volume":"101","author":"Yeh","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.104.1.15","article-title":"Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age","volume":"104","author":"O'Shea","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib8","doi-asserted-by":"crossref","first-page":"F177","DOI":"10.1136\/fn.83.3.F177","article-title":"Early postnatal dexamethasone treatment and increased incidence of cerebral palsy","volume":"83","author":"Shinwell","year":"2000","journal-title":"Arch. Dis. Child., Fetal Neonatal Ed."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/peds.107.2.217","article-title":"Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease","volume":"107","author":"Murphy","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-1-1","article-title":"The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systemic review of RCTs","volume":"1","author":"Barrington","year":"2001","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM198906083202301","article-title":"A controlled trial of dexamethasone in preterm infants at high risk of bronchopulmonary dysplasia","volume":"320","author":"Cummings","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib12","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1136\/fn.87.1.F55","article-title":"A three year follow up of preterm infants after moderately early treatment with dexamethasone","volume":"87","author":"Romagnoli","year":"2002","journal-title":"Arch. Dis. Child., Fetal Neonatal Ed."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.82.4.527","article-title":"Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period","volume":"82","author":"Shennan","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-3782(02)00039-7","article-title":"Absent or reversed end-diastolic blood flow in the umbilical artery and abnormal Doppler cerebroplacental ratio-cognitive, neurological and somatic development at 3 to 6 years","volume":"69","author":"Kutschera","year":"2002","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib15","first-page":"1","article-title":"Examination of the child with minor neurological dysfunctions","volume":"71","author":"Touwen","year":"1979","journal-title":"Clin. Dev. Med."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/088307388700200102","article-title":"Introduction to the Kaufman Assessment Battery for Children for pediatric neuroclinicians","volume":"2","author":"Kaufman","year":"1987","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.1994.tb12951.x","article-title":"Developmental screening at four years of age. Relation to home situation, perinatal stress, development and behavior","volume":"83","author":"Larsson","year":"1994","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib18","series-title":"Der Mann-Zeichen-Test","author":"Ziler","year":"1970"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/peds.107.2.217","article-title":"Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease","volume":"107","author":"Murphy","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0140-6736(00)02761-6","article-title":"Reduced development of cerebral cortex in extremely preterm infants","volume":"356","author":"Ajayi-Obe","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib21","doi-asserted-by":"crossref","first-page":"F96","DOI":"10.1136\/adc.2003.028696","article-title":"Postnatal steroid treatment and brain development","volume":"89","author":"Baud","year":"2004","journal-title":"Arch. Dis. Child., Fetal Neonatal Ed."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-4886(68)90051-4","article-title":"Reductions in size and total DANN of cerebrum and cerebellum in adult mice after corticosterone treatment in infancy","volume":"22","author":"Howard","year":"1968","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib23","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1046\/j.1471-4159.1995.64062526.x","article-title":"Opposite regulation of basic fibroblast growth factor and nerve growth factor gene expression in rat cortical astrocytes following dexamethasone administration","volume":"64","author":"Riva","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib24","doi-asserted-by":"crossref","first-page":"F102","DOI":"10.1136\/fn.86.2.F102","article-title":"Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease","volume":"86","author":"Armstrong","year":"2002","journal-title":"Arch. Dis. Child., Fetal Neonatal Ed."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib25","first-page":"897","article-title":"Controlled trial of dexamethasone in neonatal chronic lung disease. A 3-year follow up","volume":"96","author":"Jones","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib26","first-page":"CD001146","article-title":"Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants","volume":"1","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib27","first-page":"CD001144","article-title":"Moderately early (7\u201314 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","volume":"1","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.earlhumdev.2004.07.004_bib28","first-page":"CD001145","article-title":"Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants","volume":"1","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378204001343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378204001343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T18:16:14Z","timestamp":1682792174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378204001343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0378378204001343"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2004.07.004","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}